Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism
- PMID: 33446604
- PMCID: PMC8643072
- DOI: 10.1183/13993003.03434-2020
Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism
Abstract
Background: Microbiome studies of the lower airways based on bacterial 16S rRNA gene sequencing assess microbial community structure but can only infer functional characteristics. Microbial products, such as short-chain fatty acids (SCFAs), in the lower airways have significant impact on the host's immune tone. Thus, functional approaches to the analyses of the microbiome are necessary.
Methods: Here we used upper and lower airway samples from a research bronchoscopy smoker cohort. In addition, we validated our results in an experimental mouse model. We extended our microbiota characterisation beyond 16S rRNA gene sequencing with the use of whole-genome shotgun (WGS) and RNA metatranscriptome sequencing. SCFAs were also measured in lower airway samples and correlated with each of the sequencing datasets. In the mouse model, 16S rRNA gene and RNA metatranscriptome sequencing were performed.
Results: Functional evaluations of the lower airway microbiota using inferred metagenome, WGS and metatranscriptome data were dissimilar. Comparison with measured levels of SCFAs shows that the inferred metagenome from the 16S rRNA gene sequencing data was poorly correlated, while better correlations were noted when SCFA levels were compared with WGS and metatranscriptome data. Modelling lower airway aspiration with oral commensals in a mouse model showed that the metatranscriptome most efficiently captures transient active microbial metabolism, which was overestimated by 16S rRNA gene sequencing.
Conclusions: Functional characterisation of the lower airway microbiota through metatranscriptome data identifies metabolically active organisms capable of producing metabolites with immunomodulatory capacity, such as SCFAs.
Copyright ©The authors 2021. For reproduction rights and permissions contact permissions@ersnet.org.
Conflict of interest statement
Conflict of interest: I. Sulaiman has nothing to disclose. Conflict of interest: B.G. Wu has nothing to disclose. Conflict of interest: Y. Li has nothing to disclose. Conflict of interest: J-C. Tsay has nothing to disclose. Conflict of interest: M. Sauthoff has nothing to disclose. Conflict of interest: A.S. Scott has nothing to disclose. Conflict of interest: K. Ji has nothing to disclose. Conflict of interest: S.B. Koralov has nothing to disclose. Conflict of interest: M. Weiden has nothing to disclose. Conflict of interest: J.C. Clemente has nothing to disclose. Conflict of interest: D. Jones has nothing to disclose. Conflict of interest: Y.J. Huang has nothing to disclose. Conflict of interest: K.A. Stringer has nothing to disclose. Conflict of interest: L. Zhang has nothing to disclose. Conflict of interest: A. Geber has nothing to disclose. Conflict of interest: S. Banakis has nothing to disclose. Conflict of interest: L. Tipton has nothing to disclose. Conflict of interest: E. Ghedin has nothing to disclose. Conflict of interest: L.N. Segal has nothing to disclose.
Figures
Comment in
-
Is the lung microbiome alive? Lessons from Antarctic soil.Eur Respir J. 2021 Jul 29;58(1):2100321. doi: 10.1183/13993003.00321-2021. Print 2021 Jul. Eur Respir J. 2021. PMID: 34326174 No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources